Diabetische retinopathie is de meest voorkomende diabetische complicatie. De reguliere behandeling bestaat uit het stabiliseren van de bloedsuikerspiegel en bloedvetten en het monitoren van het ontstaan van oogafwijkingen. Echter, in de complementaire praktijk bestaat nog een scala aan mogelijkheden ter preventie of behandeling van de aandoening. Van suppletie met vitaminen, kruiden en voedingstoffen tot de veelbelovende toepassing van een ketogeen voedingspatroon.
Beste bezoeker, u heeft geen toegang.
Enkel (web)abonnees hebben toegang tot tijdschriftartikelen. Het webabonnement is nog in de maak.
U kunt zich wel alvast (gratis) registreren en tal van andere webartikelen raadplegen!
Auteur
Figuren
Verschenen in
Referenties
Diabetische retinopathie - Richtlijn - Richtlijnendatabase [Internet]. [cited 2022 Jun 16]. Available from: https://richtlijnendatabase.nl/richtlijn/diabetische_retinopathie/startpagina_diabetische_retinopathie.html
Diabetische retinopathie - Oogfonds [Internet]. [cited 2022 Jun 16]. Available from: https://oogfonds.nl/oogziekte/diabetische-retinopathie
Dehdashtian E, Mehrzadi S, Yousefi B, et al. Diabetic retinopathy pathogenesis and the ameliorating effects of melatonin; involvement of autophagy, inflammation and oxidative stress. Vol. 193, Life Sciences. Pergamon; 2018. p. 20–33.
Rodríguez ML, Pérez S, Mena-Mollá S, et al. Oxidative Stress and Microvascular Alterations in Diabetic Retinopathy: Future Therapies. Oxid Med Cell Longev. 2019 Nov 11;1–18.
Robles-Rivera RR, Castellanos-González JA, Olvera-Montaño C, et al. Adjuvant Therapies in Diabetic Retinopathy as an Early Approach to Delay Its Progression: The Importance of Oxidative Stress and Inflammation. Oxid Med Cell Longev. 2020 Mar 11;1–23.
Ambati J, Chalam KV, Chawala DK, et al. Elevated γ-aminobutyric acid, glutamate, and vascular endothelial growth factor levels in the vitreous of patients with proliferative diabetic retinopathy. Arch Ophthalmol. 1997 Sep 1;115(9):1161–6.
Hou XW, Wang Y, Pan CW. Metabolomics in diabetic retinopathy: A systematic review. Vol. 32, Investigative Ophthalmology and Visual Science. The Association for Research in Vision and Ophthalmology; 2021. p. 4.
Ola MS, Nawaz MI, Khan HA, et al. Neurodegeneration and neuroprotection in diabetic retinopathy. Vol. 14, International Journal of Molecular Sciences. Multidisciplinary Digital Publishing Institute; 2013. p. 2559–72.
Shi C, Wang P, Airen S, et al. Nutritional and medical food therapies for diabetic retinopathy. Eye Vis. 2020 Jun 18;7(1):1–16.
Satyanarayana A, Balakrishna N, Pitla S, et al. Status of B-Vitamins and homocysteine in diabetic retinopathy: Association with Vitamin-B12 deficiency and hyperhomocysteinemia. PLoS One. 2011 Nov 1;6(11):e26747.
Lem DW, Gierhart DL, Davey PG. A systematic review of carotenoids in the management of diabetic retinopathy. Vol. 13, Nutrients. Multidisciplinary Digital Publishing Institute; 2021. p. 2441.
Yuan X, Wang J, Yang S, et al. Effect of the ketogenic diet on glycemic control, insulin resistance, and lipid metabolism in patients with T2DM: a systematic review and meta-analysis. Vol. 10, Nutrition and Diabetes. Nature Publishing Group; 2020. p. 1–8.
Zarnowski T, Tulidowicz-Bielak M, Zarnowska I, et al. Kynurenic Acid and Neuroprotective Activity of the Ketogenic Diet in the Eye. Curr Med Chem. 2017 May 10;24(32).
Chandrasekaran P, Rani PK. Reversal of diabetic tractional retinal detachment attributed to keto diet. BMJ Case Rep. 2020 Oct 1;13(10):e235873.
Trotta MC, Maisto R, Guida F, et al. The activation of retinal HCA2 receptors by systemic beta-hydroxybutyrate inhibits diabetic retinal damage through reduction of endoplasmic reticulum stress and the NLRP3 inflammasome. PLoS One. 2019 Jan 1;14(1):e0211005.
Mudaliar S, Hupfeld C, Chao DL. SGLT2 Inhibitor-Induced Low-Grade Ketonemia Ameliorates Retinal Hypoxia in Diabetic Retinopathy-A Novel Hypothesis. Vol. 106, Journal of Clinical Endocrinology and Metabolism. Oxford Academic; 2021. p. 1235–44.
Steigerwalt R, Belcaro G, Cesarone MR, et al. Pycnogenol® improves microcirculation, retinal edema, and visual acuity in early diabetic retinopathy. J Ocul Pharmacol Ther. 2009 Dec 22;25(6):537–40.
Rossino MG, Casini G. Nutraceuticals for the treatment of diabetic retinopathy. Nutrients. 2019 Apr 2;11(4):771.
Wang W, Zhang D, Han S, et al. Effects of Ginkgo biloba extract on diabetic retinopathy: a meta-analysis and systematic review. TMR Mod Herb Med. 2020;3(4):192–201.
Schönlau F, Rohdewald P. Pycnogenol® for diabetic retinopaty: A review. Vol. 24, International Ophthalmology. Springer; 2001. p. 161–71.
